In summary, our study for the first time uncovered the oncogenic properties of SNHG3 in GC and underlined the critical contributions of MED18 in this context, although the molecular mechanism underlying the aberrant overexpression of SNHG3 in GC was currently elusive. Here, SNHG3 is linked to gastric cancer.